G1 Therapeutics to grow as it approaches filing NDA


Sailing toward a new drug application on a wave of positive data and skyrocketing stocks, one Triangle public company will also be bringing more hands on board.

Previous From St. Pete to Tampa, business and city leaders come out for Rise of Rest tour stops
Next Regulators give Johns Hopkins All Children's Hospital a second chance to redeem itself